Pathology specialist contributes to debate on breast cancer gene screening

(Women & Infants Hospital) What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? Dr. Glenn Palomaki has published an invited commentary in Genetics in Medicine on this issue.